Ticker Details
Alto Neuroscience Inc.
IPO Date:	February 2, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$744.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 4.23%
Avg Daily Range (30 D):	$0.71 | 2.91%
Avg Daily Range (90 D):	$0.75 | 3.66%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.31M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	138
Avg Institutional Trade:	$1.33M
Avg Institutional Trade (30 D):	$.77M
Avg Institutional Trade (90 D):	$.83M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.11M
Avg Closing Trade (30 D):	$.68M
Avg Closing Trade (90 D):	$.82M
Avg Closing Volume:	176.22K

News

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Oct 7, 2025 @ 10:05 PM ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi... Source: Bragar Eagel & Squire, P.C.

Sep 19, 2025 @ 8:49 PM Investors who lost money on Alto Neuroscience, Inc... Source: Levi & Korsinsky, Llp

Sep 19, 2025 @ 1:50 PM ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA... Source: Rosen Law Firm

Sep 18, 2025 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.8	$-.52
Diluted EPS		$-.8	$-.52
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-26.24M	$-14.18M
Operating Income / Loss		$-27.14M	$-14.95M
Cost of Revenue
Net Cash Flow		$87.28M
PE Ratio